RESUMEN
Two children with late-onset congenital central hypoventilation syndrome were reported, one of whom was male and had no abnormal manifestations after birth, respiratory failure occurs at the age of 1 year and 6 months. After being hospitalized, he was treated with oxygen inhalation and non-invasive ventilation, but carbon dioxide retention could not be corrected. After one month of tracheal intubation, he was failure to wean from ventilator, so tracheostomy was performed. He needs a ventilator to help breath while sleeping, and can breath autonomously during the day without ventilator. The other case was a female, with no abnormalities after birth. At the age of 11 months, she developed respiratory failure. During sleep, the child needs non-invasive assisted ventilation through a nasal mask, and during the day, she breathed autonomously.Two patients were followed up forever 2 years and their growth and development were normal.
Asunto(s)
Humanos , Niño , Masculino , Femenino , Lactante , Apnea Central del Sueño/terapia , Respiración Artificial , Hipoventilación/congénito , OxígenoRESUMEN
Congenital central hypoventilation syndrome (CCHS) and rapid-onset obesity syndrome with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) are rare causes of hypoventilation during sleep in the pediatric population. This group of disorders are characterized by the absence or decrease in the automatic control of ventilation, decreased sensitivity of chemoreceptors to CO2, causing hypoventilation during sleep and even in wakefulness, in the most severe cases. For these reasons it is important to diagnose and treat them promptly. The objective of this review is to provide current and complete literature, to be able to identify, treat and refer this group of children early, and thus reduce the complications and/or associated comorbidities in the short and long term, improving their quality of life.
El síndrome de hipoventilación central congénita (CCHS) y síndrome de obesidad de inicio rápido con disfunción hipotalámica, hipoventilación y desregulación autonómica (ROHHAD), son causas poco comunes de hipoventilación durante el sueño en la población pediátrica. Este grupo de trastornos se caracterizan por ausencia o disminución en el control automático de la ventilación, sensibilidad disminuida de los quimioreceptores al CO2, provocando hipoventilación durante el sueño e incluso en vigilia, en los casos más severos. Por estas razones es importante diagnosticarlos y tratarlos oportunamente. El objetivo de esta revisión es proporcionar literatura actual y completa, para poder identificar, tratar y referir a éste grupo de niños tempranamente, y así disminuir las complicaciones y/o comorbilidades asociadas a corto y largo plazo, mejorando su calidad de vida.
Asunto(s)
Humanos , Niño , Síndrome de Hipoventilación por Obesidad/fisiopatología , Trastornos del Sueño-Vigilia/fisiopatología , Hipoventilación/fisiopatología , Síndrome de Hipoventilación por Obesidad/complicaciones , Pronóstico , Respiración Artificial , Sueño , Trastornos del Sueño-Vigilia/diagnóstico , Trastornos del Sueño-Vigilia/etiología , Trastornos del Sueño-Vigilia/terapia , Polisomnografía , Hipoventilación/complicaciones , Hipoventilación/congénito , Hipoventilación/diagnóstico , Hipoventilación/terapiaRESUMEN
Resumen: Introducción: El marcapasos diafragmático permite reducir o eliminar la necesidad de ventilación mecánica en pacientes con insuficiencia respiratoria crónica que conservan el eje nervio frénico-diafragma in tacto, siempre que no presenten enfermedad pulmonar intrínseca. Aunque su implantación ha sido practicada por décadas, su uso no está ampliamente difundido, y existe poca literatura pu blicada al respecto, la mayoría relacionada con lesión medular alta y síndrome de hipoventilación central congénito. Objetivo: Describir una experiencia de implantación de marcapasos diafragmático en paciente pediátrico con síndrome de hipoventilación central adquirido. Caso Clínico: Pa ciente femenino con síndrome de hipoventilación central secundario a lesión isquémica de tronco cerebral como resultado de disfunción de válvula de derivación ventrículo peritoneal, motivo por el cual durante 5 años se mantuvo con asistencia de ventilación mecánica intrahospitalaria. A los 7 años de edad se implantó marcapasos diafragmático mediante cirugía toracoscópica, lo que per mitió posterior a un periodo de rehabilitación y acondicionamiento respiratorio el destete de la ventilación mecánica y el egreso hospitalario. Conclusiones: El marcapasos diafragmático es una opción factible, potencialmente segura y costo efectiva para disminuir o eliminar la dependencia de ventilación mecánica y mejorar la calidad de vida en pacientes con síndrome de hipoventilación central adquirido.
Abstract: Introduction: Diaphragmatic pacemaker is a device that reduces or eliminates the need of mechanical ventilation in patients with chronic respiratory failure who keep the phrenic nerve-diaphragm axis intact, as long as they do not present intrinsic lung disease. Although its implantation has been practiced for deca des, its use is not widespread and to date, there is little published literature about it, mostly related to high spinal cord injury and congenital central hypoventilation syndrome. Objective: To describe an experience of diaphragmatic pacemaker implantation in a pediatric patient with acquired cen tral hypoventilation syndrome. Clinical Case: Female patient with central hypoventilation syndrome secondary to ischemic brainstem lesion as a result of ventriculoperitoneal shunt malfunction. For this reason, for 5 years she was supported by inpatient mechanical ventilation. At 7 years of age, a diaphragmatic pacemaker was implanted by thoracoscopic surgery, which allowed, after a period of rehabilitation and respiratory conditioning, mechanical ventilation withdrawal, and hospital dischar ge. Conclusions: Diaphragmatic pacemaker is a feasible, potentially safe, and cost-effective option for decreasing or eliminating mechanical ventilation dependence and improve life quality in patients with acquired central hypoventilation syndrome.
Asunto(s)
Humanos , Femenino , Niño , Marcapaso Artificial , Diafragma , Hipoventilación/terapia , Síndrome , Toracoscopía , Hipoventilación/etiologíaRESUMEN
Central hypoventilation syndrome is a rare and fatal condition resulting from various central nervous system disorders that is characterized by a failure of automatic breathing. We report a case of central hypoventilation syndrome following posterior circulation stroke whose pulmonary function was improved by respiratory rehabilitation. A 59-year-old woman with a history of hemorrhagic stroke of the bilateral cerebellum was hospitalized due to pneumonia. A portable ventilator was applied via tracheostomy, recurrent episodes of apnea and hypercapnia impeded weaning. A respiratory rehabilitation program including chest wall range of motion exercise, air stacking exercise, neuromuscular electrical stimulation (NMES) on abdominal muscles, upper extremity ergometer, locomotor training, high-frequency chest wall oscillator, mechanical insufflation, and exsufflation was employed, as spirometry showed a severe restrictive pattern. A spontaneous breathing trial was started, and a portable ventilator was applied for 8 hours, only during nighttime, to prevent sudden apneic event. After 4 weeks of treatment, follow-up spirometry showed much improved respiratory parameters. This case suggests that respiratory rehabilitation can improve pulmonary function parameters and quality of life in central hypoventilation syndrome.
Asunto(s)
Femenino , Humanos , Persona de Mediana Edad , Músculos Abdominales , Apnea , Enfermedades del Sistema Nervioso Central , Cerebelo , Estimulación Eléctrica , Estudios de Seguimiento , Hipercapnia , Hipoventilación , Insuflación , Neumonía , Calidad de Vida , Rango del Movimiento Articular , Rehabilitación , Respiración , Centro Respiratorio , Espirometría , Accidente Cerebrovascular , Pared Torácica , Traqueostomía , Extremidad Superior , Ventiladores Mecánicos , DesteteRESUMEN
BACKGROUND: Congenital central hypoventilation syndrome (CCHS) is a rare disorder characterized by alveolar hypoventilation and autonomic dysregulation. Patients with CCHS have adequate ventilation while awake but exhibit hypoventilation while asleep. More severely affected patients exhibit hypoventilation both when awake and when asleep. CASE: Here, we report a case of successful spinal anesthesia and postoperative epidural analgesia in a patient with CCHS who underwent orthostatic surgery. CONCLUSIONS: In patients with CCHS, anesthesia is used with the goal of minimizing respiratory depression to avoid prolonged mechanical ventilation. Regional anesthesia should be considered where appropriate. Continuous oxygen saturation and end-tidal carbon dioxide monitoring must be available.
Asunto(s)
Humanos , Analgesia Epidural , Anestesia , Anestesia de Conducción , Anestesia Raquidea , Hipoxia , Dióxido de Carbono , Hipoventilación , Oxígeno , Respiración Artificial , Insuficiencia Respiratoria , VentilaciónRESUMEN
Congenital central hypoventilation syndrome (CCHS) is a rare genetic disorder characterized by ventilatory insensitivity to hypercapnia and hypoxemia during sleep and/or wakefulness presenting in infancy,childhood or adulthood.Paired-like homeobox 2B (PHOX2B) is the disease-defining gene for CCHS,which includes 2 mutation types,polyalanine repeat expansion mutation(PARM) and non-PARM.The CCHS-phenotype is associated with PHOX2B genotype.Children with CCHS typically have normal breathing when awake,while have progressive shallow breathing,cyanosis,hypercapnia and hypoxemia when asleep,but they don't response with respiratory effort.CCHS patients mainly present at birth,some may present in adult years.CCHS is also associated with generalized dysfunction of the autonomic nervous system,and Hirschsprung disease and tumors of neural crest origin are associated with the disease.Non-invasive ventilation is an effective treatment and it can increase the quality of life for CCHS patient.
RESUMEN
Objective To study the molecular genetic mechanism of congenital central hypoventilation syndrome ( CCHS).Method The clinical data and molecular genetics results of CCHS diagnosed in neonatology department from 2014 to 2016 were analyzed retrospectively.The relationship between genotypes and clinical phenotypes in patients of CCHS was analyzed , and the diagnostic thinkings , follow-up and prognosis were summarized.Result A total of 4 infants with CCHS were included in this study.Among them, 2 were boys and the other 2 were girls.They were all full-term neonates without asphyxia at birth , but they soon sufferd from dyspnea and cyanosis , required assisted ventilation.One case had difficult defecation. All 4 cases had difficulty in weaning.The respiratory rhythm became weak developed apnea and carbon dioxide retention was detected in blood gas analysis.All the 4 cases died after withdrawal of treatment.The results of molecular genetic testing were as follows.There was a 38bp heterozygous deletion mutation in exon 3 of gene PHOX2B ( e.756_776 del21bp).Three cases were found small fragment insertion in exon 3 of gene PHOX2B, which attributed to polyalanine repeat expansion mutations (PARMs).One case belonged to type 20/27 and another 2 cases belonged to type 20/26.Conclusion The main manifestation of CCHS in the neonatal period is ventilator dependant , which can combined with megacolon and atypical autonomic nerve disorder.According to the literature, more than 95%of CCHS are caused by the PHOX2B mutation. The symptom is severe when it got a non-PARMs mutation.It′s useful to make a definite diagnosis with genetic diagnosis results , which could be helpful for treating and predicting.Only effective respiratory support and standardized follow-up system can improve the quality of life in patients of CCHS.
RESUMEN
@#Haddad syndrome is a rare congenital disorder in which congenital central hypoventilation syndrome (CCHS) occurs with Hirschsprung’s disease. It is extremely rare with only more than 60 cases reported in the worldwide literature. We report on a Filipino newborn male infant who presented with signs and symptoms of progressive abdominal enlargement, bowel obstruction, and recurrent hypoventilation. The diagnosis of Haddad syndrome was made clinically and confirmed by sequence analysis of the PHOX2B gene which showed a 27repeat heterozygous expansion of the polyalanine-coding region. All CCHS patients require assisted ventilation especially during sleep to prevent lung atelectasis and other complications. An early diagnosis and confirmation by genetic testing is vital for proper management of affected patients.
Asunto(s)
Enfermedad de HirschsprungRESUMEN
Congenital central hypoventilation syndrome (CCHS)is a rare disorder characterized by hypoventilation during sleep and blunted ventilatory responses to hypercapnia and hypoxemia.It is normally found in neonatal and infant.Late-onset cases have been reported recently.The paired-like homeobox gene PHOX2B is the disease-defining gene for CCHS;a mutation in the PHOX2B gene is requisite to the diagnosis of CCHS.As a lifelong disease,the key treatment is ensuring adequate ventilation and oxygenation,effective modalities include positive pressure ventilation,negative pressure ventilation and diaphragmatic pacing.The strategy of anti-mutant protein and the use of progestin open up clinical perspectives to enhance ventilation in CCHS patients.
RESUMEN
Abstract Objective: To report the case of a newborn with recurrent episodes of apnea, diagnosed with Congenital Central hypoventilation syndrome (CCHS) associated with Hirschsprung's disease (HD), configuring Haddad syndrome. Case description: Third child born at full-term to a non-consanguineous couple through normal delivery without complications, with appropriate weight and length for gestational age. Soon after birth he started to show bradypnea, bradycardia and cyanosis, being submitted to tracheal intubation and started empiric antibiotic therapy for suspected early neonatal sepsis. During hospitalization in the NICU, he showed difficulty to undergo extubation due to episodes of desaturation during sleep and wakefulness. He had recurrent episodes of hypoglycemia, hyperglycemia, metabolic acidosis, abdominal distension, leukocytosis, increase in C-reactive protein levels, with negative blood cultures and suspected inborn error of metabolism. At 2 months of age he was diagnosed with long-segment Hirschsprung's disease and was submitted to segment resection and colostomy through Hartmann's procedure. A genetic research was performed by polymerase chain reaction for CCHS screening, which showed the mutated allele of PHOX2B gene, confirming the diagnosis. Comments: This is a rare genetic, autosomal dominant disease, caused by mutation in PHOX2B gene, located in chromosome band 4p12, which results in autonomic nervous system dysfunction. CCHS can also occur with Hirschsprung's disease and tumors derived from the neural crest. There is a correlation between phenotype and genotype, as well as high intrafamilial phenotypic variability. In the neonatal period it can simulate cases of sepsis and inborn errors of metabolism.
Resumo Objetivo: Relatar caso de neonato com episódios de apneias recorrentes, diagnosticado com síndrome de hipoventilação central congênita (SHCC) associada à doença de Hirschsprung (DH), o que configurou síndrome de Haddad. Descrição do caso: Terceiro filho de casal não consanguíneo, nascido a termo, parto normal sem intercorrências, peso e comprimento adequados para idade gestacional. Logo após o nascimento apresentou bradipneia, bradicardia e cianose, foi submetido à intubação orotraqueal e iniciada antibioticoterapia empírica devido à suspeita de sepse neonatal precoce. Durante internação em UTI neonatal evoluiu com dificuldade de extubação devido a episódios de dessaturação durante sono e vigília. Apresentou quadros recorrentes de hipoglicemia, hiperglicemia, acidose metabólica, distensão abdominal, leucocitose, aumento de proteína C reativa, com hemoculturas negativas e suspeita de erro inato do metabolismo. Aos dois meses foi diagnosticada doença de Hirschsprung de segmento longo, foi submetido à ressecção do segmento e colostomia à Hartmann. Feita pesquisa genética por reação em cadeia da polimerase para pesquisa de SHCC, que evidenciou alelo mutado do gene PHOX2B e confirmou o diagnóstico. Comentários: Trata-se de doença genética rara, de herança autossômica dominante, causada por mutação no gene PHOX2B, localizado na banda cromossômica 4p12, que resulta em disfunção do sistema nervoso autônomo. A SHCC também pode cursar com doença de Hirschsprung e tumores derivados da crista neural. Há correlação entre fenótipo e genótipo, além de grande variabilidade fenotípica intrafamiliar. No período neonatal pode simular quadros de sepse e erros inatos do metabolismo.
Asunto(s)
Humanos , Masculino , Recién Nacido , Apnea Central del Sueño/complicaciones , Hipoventilación/congénito , Enfermedad de Hirschsprung , Hipoventilación/complicacionesRESUMEN
Congenital central hypoventilation syndrome,also known as “Ondine′s curse”,is charac-terized by hypoventilation during sleep and impaired ventilatory responses to hypercapnia and hypoxemia. This disorder is associated with a malfunction of the nerves that control involuntary body functions and abnor-mal development of early embryonic cells that form the spinal cord. This review summarized the latest pro-gression in the pathogenesis,clinical symptoms,diagnosis,treatment and prognosis.
RESUMEN
Congenital central hypoventilation syndrome (CCHS) is a life-threatening disease that primarily manifests as sleep-associated respiratory insufficiency and a markedly impaired ventilatory response to hypercarbia and hypoxemia. Paired-like homeobox 2b (PHOX2B) gene mutations are known to cause CCHS. Almost all patients with CCHS are heterozygous for a poly-alanine expansion in PHOX2B. However, some patients have other germ-line abnormalities, including missense, nonsense and frame shift mutations. CCHS combined with Hirschsprung disease (Haddad syndrome) is extremely rare. Here, we report the case of a 1-day-old male neonate with recurrent apnea and bowel distension. Genetic analysis showed that he was heterozygous for a germ-line mutation in the PHOX2B gene. Only three cases of CCHS including two with Haddad syndrome confirmed by PHOX2B gene mutations have been reported in Korea. All of these cases have been heterozygous for a poly-alanine expansion mutation. This is the first report describing Haddad syndrome with a germ-line mutation in the PHOX2B gene in a Korean neonate.
Asunto(s)
Humanos , Recién Nacido , Masculino , Hipoxia , Apnea , Mutación del Sistema de Lectura , Genes Homeobox , Mutación de Línea Germinal , Enfermedad de Hirschsprung , Hipoventilación , Corea (Geográfico) , Insuficiencia RespiratoriaRESUMEN
Congenital central hypoventilation syndrome (CCHS) is a disorder of the autonomic nervous system characterized by a decreased response to hypercarbia. CCHS is frequently associated with congenital megacolon; the combination is called Haddad syndrome. CCHS is associated with dysfunction in respiratory features of the autonomic nervous system and with other disorders, including facial deformities, cardiovascular symptoms, and tumors. Patients with CCHS frequently have a mutation in the homeobox protein 2b (PHOX2B) gene. Most mutations involve heterozygous expansion of alanine repeats (GCN). Interestingly, a higher polyalanine repeat number is associated with a more severe clinical phenotype. To clarify the role of PHOX2B in disease pathogenesis, we introduce and review the clinical and molecular features of CCHS and Haddad syndrome.
Asunto(s)
Humanos , Alanina , Sistema Nervioso Autónomo , Anomalías Congénitas , Genes Homeobox , Enfermedad de Hirschsprung , Hipoventilación , Biología Molecular , FenotipoRESUMEN
El Síndrome de Hipoventilación Central (SHC), conocido como Síndrome de Ondina, generalmente se presenta en el periodo neonatal y se caracteriza por hipoventilación alveolar en ausencia de enfermedades cardiopulmonares y neuromusculares. Se ha descrito que las mutaciones en el gen PHOX2B son las responsables de SHC. El principal objetivo del tratamiento del síndrome es asegurar una buena ventilación durante la vigilia y el sueño. Muchos de estos pacientes viven una vida plena.Se presenta el caso de un paciente de cinco meses de edad con diagnóstico de SHC, el cual presentó episodios cianozantes y desaturaciones de oxígeno persistentes, con buena respuesta al manejo médico con metilfenidato.
Central Hypoventilation Syndrome (SHC), known as Ondine syndrome, usually occurs during the neonatal period,this entity is characterized by alveolar hypoventilation in the absence of cardiopulmonary and neuromusculardiseases. It has been reported in mutations of PHOX2B gene. The primary goal of treatment for the SHC is to ensure good ventilation during wakefulness and sleep. Many of these patients live a full life.We report the case of a five-month-old baby diagnosed with SHC, which had episodes of persistent low oxygen saturations, with good response to medical treatment with methylphenidate.
Asunto(s)
Humanos , Hipoxia , Apnea Central del Sueño , Genes , HipercapniaRESUMEN
Chronic hypoventilation due to injury to the brain stem respiratory center or high cervical cord (above the C3 level) can result in dependence to prolonged mechanical ventilation with tracheostomy, frequent nosocomial pneumonia, and prolonged hospitalization. Diaphragm pacing through electrical stimulation of the phrenic nerve is an established treatment for central hypoventilation syndrome. We performed chronic phrenic nerve stimulation for diaphragm pacing with the spinal cord stimulator for pain control in a quadriplegic patient with central apnea due to complete spinal cord injury at the level of C2 from cervical epidural hematoma. After diaphragmatic pacing, the patient who was completely dependent on the mechanical ventilator could ambulate up to three hours every day without aid of mechanical ventilation during the 12 months of follow-up. Diaphragm pacing through unilateral phrenic nerve stimulation with spinal cord stimulator was feasible in an apneic patient with complete quadriplegia who was completely dependent on mechanical ventilation. Diaphragm pacing with the spinal cord stimulator is feasible and effective for the treatment of the central hypoventilation syndrome.
Asunto(s)
Humanos , Apnea , Tronco Encefálico , Diafragma , Estimulación Eléctrica , Estudios de Seguimiento , Hematoma , Hospitalización , Hipoventilación , Nervio Frénico , Neumonía , Cuadriplejía , Respiración Artificial , Centro Respiratorio , Apnea Central del Sueño , Médula Espinal , Traumatismos de la Médula Espinal , Traqueostomía , Ventiladores Mecánicos , Heridas y LesionesRESUMEN
Objective This study aimed to explore the clinical characteristics and treatment of congenital central hypoventilation syndrome(CCHS),to raise awareness on the CCHS for early diagnosis and treatment.Methods The clinical data of 4 babies with CCHS were analyzed,all of the babies were repeated bruising,hypercapnia,and difficult-to-wean.After the relevant checks,we precluded the primary diseases of heart,lung and neuromuscular dysfunction that lead to low ventilation,and detected the major pathogenic genes,Phox2b of CCHS,refer to literature and diagnostic criteria of CCHS.Results Four babies all had typical clinical features of CCHS:enough ventilation when awake.But when they were asleep,their respiratory rate slowed down,hypoventilation,cyanosis and hypercapnia appeared,and they can not be awaked by hypercapnia and hypoxemia caused by hypoventilation.Genetic testing confirmed the presence of Phox2b mutations.Two infants were supported by non-invasive biphasic positive airway pressure(BiPAP),an infant was discharged home at 3 months of age with non-invasive BiPAP,and an infant was discharged home at 1 month of age.Both of them were monitored and treated at home,and showed normal development.Conclusion For babies who were repeated bruising,hypercapnia,and difficult-to-wean,but no primary diseases of heart,lung and neuromuscular dysfunction that lead to low ventilation,CCHS must be considered.Genetic testing of Phox2b can be used as an important diagnostic tool,and non-invasive BiPAP is one of the efficacious methods in the treatment of CCHS.
RESUMEN
Congenital central hypoventilation syndrome with Hirschsprung's disease, also known as Haddad syndrome, is an extremely rare disorder with variable symptoms. Recent studies described that congenital central hypoventilation syndrome had deep relation to the mutation of the PHOX2B gene in its diagnosis and phenotype. We report a newborn male infant with clinical manifestations of recurrent hypoventilation with hypercapnea and bowel obstruction. These clinical manifestations were compatible with congenital central hypoventilation syndrome and Hirschsprung's disease, and polyalanine 26 repeats in the PHOX2B gene supported the diagnosis of congenital central hypoventilation. We described a first case of Haddad syndrome in Korean and its clinical and genetic characteristics were discussed.
Asunto(s)
Humanos , Recién Nacido , Masculino , Pueblo Asiatico , Secuencia de Bases , Análisis Mutacional de ADN , Enfermedad de Hirschsprung/diagnóstico , Proteínas de Homeodominio/genética , Hipoventilación/congénito , Datos de Secuencia Molecular , Mutación , Apnea Central del Sueño/diagnóstico , Factores de Transcripción/genéticaRESUMEN
Haddad syndrome is an extremely rare disorder which combines congenital central hypoventilation syndrome (CCHS) and Hirschsprung's disease. Several reports have demonstrated that CCHS was related to mutation of the PHOX2B gene. We report here a newborn male infant with apnea and bowel obstruction. He has been diagnosed with combined congenital central hypoventilation syndrome and Hirschsprung's disease, and had 27 polyalanine repeats in the PHOX2B gene. Two cases of Haddad syndrome with identified PHOX2B gene mutation have been recently reported in Korea. Both of them had extended alleles containing 26 polyalanine repeats. It is known that increased number of polyalanine repeat mutations is associated with a more severe clinical phenotype. The baby reported here had 27 alanine repeats (i.e. one more than the previously reported cases in Korea) and ganglion cells could be found only in the distal 70 cm of his small bowel.
Asunto(s)
Humanos , Lactante , Recién Nacido , Masculino , Alanina , Alelos , Apnea , Ganglión , Enfermedad de Hirschsprung , Hipoventilación , Corea (Geográfico) , Péptidos , Fenotipo , Síndrome del Intestino Corto , Apnea Central del SueñoRESUMEN
Congenital central hypoventilation syndrome (CCHS) is a life-threatening disorder with apnea and cyanosis during sleep requiring immediate endotracheal intubation during the first day of life. The PHOX2B gene has been identified as the major gene involved in CCHS. This is the first report of a Korean neonate with CCHS confirmed to have a PHOX2B mutation with expanded alleles containing 20 polyalanine repeats that is a relatively small number compared to previous cases. The patient required intermittent ventilator support during sleep only and did not suffer from any other disorders of the autonomic nerve system. He consistently needs ventilator support during sleep and remains alive. Analysis of PHOX2B gene is useful for diagnosis and appropriate therapeutic intervention of CCHS patients.
Asunto(s)
Humanos , Recién Nacido , Masculino , Alelos , Pueblo Asiatico/genética , Genotipo , Proteínas de Homeodominio/genética , Hipoventilación/congénito , Mutación , Péptidos/genética , República de Corea , Análisis de Secuencia de ADN , Factores de Transcripción/genética , Ventiladores MecánicosRESUMEN
Objetivo: relatar o caso de uma criança recém-nascida (RN) com comprometimento do sistema nervoso autônomo caracterizado por insensibilidade em detectar aumento de CO2 e diminuição de O2, denominado de Maldição de Ondina ou Síndrome da Hipoventilação Central Congênita ou Hipoventilação Alveolar Primária, com ênfase ao acompanhamento fonoaudiológico. Discussão: o diagnóstico de Maldição de Ondina deve ser aventado quando da presença de episódios de apneias em RN, sem que se consiga elucidar a causa e que seja afastada a possibilidade de crise epiléptica, distúrbio pulmonar e/ou cardíaco, lesão de tronco ou de outra região encefálica. A evolução respiratória desta criança foi de dependência do respirador por 24 horas até o final do terceiro mês de vida. Progressivamente, foi possível deixá-la com cateter nasal com fluxo contínuo de oxigênio enquanto se mantinha acordada, e respirador em modo controlado nos períodos de sono. O tratamento específico, com instalação de marca-passo diafragmático, é a única terapia existente até o momento.
Purpose: To report the case of a newborn (NB) with an autonomic nervous system disorder characterized by insensitivity to detect increased CO2 and decreased O2, referred to as Ondine's curse, Primary Hypoventilation Syndrome, or Congenital Central Alveolar Hypoventilation, with emphasis on speech therapy. Discussion: The diagnosis of Ondine's curse should be considered upon presence of episodes of apnea in newborns, with no clear indication of the cause and with no indications of seizures, severe pulmonary or cardiac injury of the brainstem or another cerebral region. The respiratory development characteristic of this child was being ventilator dependent for 24 hours a day until the end of the third month of life. Gradually, it was possible to leave the device with a continuous nasal oxygen flow while awake, and breathing with a ventilator under control during her periods of sleep. Specific treatment with installation of diaphragmatic pacemaker, is the only treatment available to date.
Objetivo: relatar el caso de un recién nacido (RN) con comprometimiento del sistema nervioso autónomo caracterizado por falta de sensibilidad para detectar el aumento de la emisión de CO2 y la disminución de O2, conocido como La Maldición de Ondina, o Síndrome de Hipoventilación Central Congénita o Hipoventilación Alveolar Primaria, con énfasis al acompañamiento fonoaudiológico. Discusión: El diagnóstico de la Maldición de Ondine debe ser considerado en la presencia de episodios de apnea en recién nacidos, sin que se pueda aclarar la causa y que sea rechazada la posibilidad de crisis epiléptica, trastorno pulmonar y/o cardiaco severo, lesión de tronco o otra región encefálica. El desarrollo respiratorio de este niño fue de dependencia del respirador por 24 horas hasta el final del tercer mes de vida. Progresivamente fue posible dejarla con un flujo nasal continuo de oxígeno mientras se mantenía despierta, y con respirador en forma controlada durante los períodos de sueño. El tratamiento específico con la instalación de un marcapasos diafragmático, es el único tratamiento disponible hasta la fecha.